Global Softgel Capsules Market By Type (Gelatin type), By Application (Pharmaceutical and Health Supplements), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2030 (Includes Business Impact of COVID-19)

                                          
Report updated on 11th September, 2021: Global Softgel Capsules Market By Type (Gelatin type), By Application (Pharmaceutical and Health Supplements), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2030 (Includes Business Impact of COVID-19)
Trusted Business Insights has published a comprehensive market research report on, Global Softgel Capsules Market by Product Type (Standard and Vegetarian), By Application (Pharmaceuticals, Nutraceuticals and Cosmetics), and by Region -Global Forecast to 2030, which offers a holistic view of the global Softgel Capsules market through systematic segmentation that covers every aspect of the target market.

The global Softgel Capsules market is projected to be US$ 2,471.1 Mn in 2020 to reach US$ 4,052.1 Mn by 2030 at a CAGR of 5.1%.

A softgel capsule is a solid capsule surrounding a liquid or semi-solid center. These capsules generally contain the drug in a non-aqueous solution or suspension. For the outer shell and inner fill, an active ingredient can be incorporated. The shells are made with gelatin, water, opacifier and a plasticizer such as glycerin and sorbitol. These capsules are easy to swallow, tamper-proof, and have no taste. Softgel capsules are oral dosage form for medicine similar to capsules and come in a variety of colors, shapes, and size.

Softgel capsules are a case produced from a single piece of gelatin, rather than two halves attached. They are used for oil-based solutions, as a water-based solution would dissolve the gelatin. Once the capsule is ingested, the active ingredient in oil-based solution dissolves within the body, releasing the drug. The softgel capsule is manufactured and filled using the same machine as part of a single process, and some have the brands or dosage strength printed on them.

Apart from standard softgel capsules, vegetarian softgel capsules are now available in the market. Standard softgel capsules are made with gelatin which comes from bovine or pigs. Whereas, vegetarian softgel capsules are produced using vegetable cellulose. Generally, the bark of the pine and spruce trees are the source of vegetable cellulose. As softgel vegetarian capsules are not made with animal byproducts, they are suitable for individuals who choose not to consume products sourced from animals. Therefore, growing demand for natural and products that are free from animal derivatives is creating significant growth opportunities for these types of capsules.


Global Softgel Capsules Market Revenue (US$ Mn), 2021 to 2030


Softgel capsules manufacturers are undertaking various activities to provide unique empty softgel capsules which are more adaptable and convenient for pharmaceutical, nutraceutical, and cosmeceutical industry applications. Pharmaceutical and nutraceutical industries prefer empty softgel capsules due to their suitable properties for different formulations such as solid and liquid dosage forms. Hence, increasing inclination of the pharmaceutical and nutraceutical industry towards empty softgel capsules is likely to assist the target market growth.
The high cost of vegetarian softgel capsules and rising dissatisfaction with quality standards are hampering the growth of target market globally

Global Softgel Capsules market is segmented on the basis of product type, application, and region. Based on product type, the market is segmented into Standard and Vegetarian. The Vegetarian segment accounts for the majority share and is expected to register the highest growth over the forecast period. Based on application, the market is segmented into Pharmaceuticals, Nutraceuticals, and Cosmetics. The Nutraceutical segment accounts for a majority share in the global Softgel Capsules market.


Global Softgel Capsules Market By Application, 2018


Based on the region, the market is segmented into North America, Europe, APAC, South America, and Middle East Africa. North America accounts for the majority share in the global Softgel Capsules market, owing to increasing spending on pharmaceuticals R&D. APAC is expected to register highest growth rate over forecast period. Regions such as Europe, South America, and MEA are expected to register stable growth over the forecast period.

The research report on the global Softgel Capsules market includes profiles of some of major companies such as Thermo Fisher Scientific Inc., Catalent, Inc., Lonza Group, Captek Softgel International, Inc., Sirio Pharma Company Limited, Fuji Capsule Co., Ltd., Weihai Baihe Biology Technological Co., Ltd, Aenova Group, Soft Gel Technologies, Catalent Pharma Solutions, Procaps, Strides Pharma, International Vitamin Corp., China Shineway Pharma, Guangdong Yichao Biological Co., Ltd. etc.



Below are the active patents related to Softgel Capsules Market.


Patent Number: US7662406B1

Chewable softgel capsules

Abstract

A chewable softgel capsule configured for encasing orally ingestible articles. The chewable soft capsule is provided with an outer shell composition which comprises at least one gelatin in a range of 20% to 60% of the total weight of the shell composition, at least one plasticizer in an amount selected to render flexible the outer shell composition, an anti-tacking agent in an amount selected to render the outer shell composition non-sticky, and water. In one embodiment the chewable soft capsule further comprises at least one starch in a range of 0.1% to 35% of the total weight of the shell composition. The chewable softgel capsule is suitable for encasing therein medicines, pharmaceutical compositions, nutraceuticals, vitamins, nutritional supplements, and the like.

Application File Date: 2009-08-18

Application Granted Date: 2010-02-16

Current Assignee: Viva Pharmaceutical Inc

Patent Number: EP1680096A1

New formulation for retinoid-containing soft gelatin capsules

Abstract

A new pharmaceutical formulation for retinoid-containing soft gelatin capsules is disclosed. The new formulation comprises a soft gelatin capsule filled with a fill mass comprising a retinoid as an active ingredient, a natural vegetable oil, a partially hydrogenated natural vegetable oil and medium chain triglycerides. Optionally, the new formulation also comprises a natural wax. In a particularly preferred embodiment, the soft gelatin capsule comprises pig gelatin in the capsule shell in combination with the above fill mass.

Application File Date: 2004-10-28

Application Granted Date: 2008-04-16

Current Assignee: Basilea Pharmaceutica AG

Patent Number: US20150272895A1

Composition of vegetable soft capsule having excellent elasticity and adhesive property, provided in form of thin film, and having improved productivity and disintegration, and method of preparing the same

Abstract

Disclosed are a composition of a vegetable soft capsule having excellent elasticity and an excellent adhesive property, provided in the form of a thin film, and having improved productivity and disintegration, and a method of preparing the same. Based on 35.3 weight part of the starch and the carrageenan, 7 weight part of the starch and 3 weight part of carrageenan are provided. In 35.3 weight part of the starch and the carrageenan, the starch contains 17.65 weight part of corn starch, 3.53 weight part of tapioca starch, and 3.53 weight part of potato starch are provided based on the weight ratio, and the carrageenan contains 7.592 weight part of iota carrageenan, 2.118 weight part of kappa carrageenan, 0.8 weight part of baking soda (sodium bicarbonate), 0.04 weigh part of arabic gum, and 0.04 weight part of Levan. Together with 35.3 weight part of the starch and the carrageenan, 17.7 weight part of glycerin, and 47 weight part of purified water are composited.

Application File Date: 2015-03-30

Application Granted Date: 2016-09-27

Current Assignee: CHANG SUNG SOFTGEL SYSTEM Ltd

Key Market Segments:

By Type

  
Gelatin Capsules
  
Non-Animal Softgel Capsules

  
Starches
  
Pullulan
  
Ohers



By Application

  
Prescription Medicines
  
Health & Dietary Supplements

By Manufacturers

  
Pharmaceutical Companies
  
Nutraceutical Companies
  
Others


Key Market Players included in the report:


  
Aenova Group GmbH
  
BASF SE
  
Capsugel
  
Captek Softgel International Inc.
  
Catalent Pharma Solutions
  
China Shineway Pharma
  
Colorcon Inc.
  
Elnova Pharma
  
EuroCaps Ltd (part of DCC Plc)
  
Fuji Capsules Co. Ltd.
  
Guangdong Yichao Biological Co.Ltd.
  
Hunan Er-Kang Pharmaceutical Co.Ltd
  
InovoBiologic Inc.
  
International Vitamin Corp.
  
KD Pharma Group
  
Lonza Group Ltd.
  
NOW Foods Inc.
  
ProCaps Laboratories
  
Sirio Pharma Company Limited
  
Soft Gel Technologies
  
Strides Pharma
  
Super Spectrim
  
Thermo Fisher Scientific Inc.
  
Trigen Laboratories Inc.
  
Weihai Baihe Biology Technological Co. Ltd


Below are the key development related to Softgel Capsules Market in 2020 and 2021.


May 2021: CBD Healthcare company Opticann launches ArthroCBD, a line of scientifically proven softgel capsules. BOULDER, Colo. ArthroCBD is an innovative hemp brand created to provide a solution to those seeking symptomatic relief. The new product is backed by unmatched scientific clinical data published in a peer reviewed journal. ArthroCBD is a softgel capsule with 25 mg of CBD and 6 mg of Beta caryophyllene, and is formulated using VESIsorb®, which provides dramatically improved 4.4x absorption versus competitive oral CBD products on the market. These absorption levels result in rapid onset of action and long-lasting relief. ArthroCBD also has all traces of THC removed to avoid the problematic adverse effect people can get from many other hemp-based products. Source

January 2021: Lonza to Exit Pharma Softgels and Liquid-Filled Hard Capsules NextPharma to acquire sites in France and UK specialized in lipid oral finished dosage forms. Lonza and NextPharma have formed an agreement for the potential sale of Lonzas Ploermel, France and Edinburgh, UK sites, subject to relevant conditions and regulatory approvals. The Ploermel and Edinburgh sites employ around 260 and 130 permanent staff respectively. They produce liquid-filled hard capsules, including Licaps, and softgels for high potent and hormonal products. NextPharma offers specialized contract development and manufacturing organization (CDMO) services in oral and topical, including sterile ophthalmic, finished dosage forms. With this intended acquisition, NextPharma plans to develop and broaden its technology offering into lipid based finished dosage forms—softgels and liquid-filled hard capsules—in addition to offering high potency capabilities and New Chemical Entity (NCE) development services to both its existing and new customers. With this intended divestment, Lonza plans to exit both softgels and liquid-filled hard capsules for the pharma market, aside from retaining capability for feasibility studies as part of a technology selection offering. In the consumer health and nutrition space, Lonza plans to exit softgels but continue to offer Licaps-based products (lipid capsules) out of Colmar (FR), Greenwood (US) & Sagamihara (JP). Capsules, including Licaps for nutrition, remain core to Lonza’s offering and the company has recently announced an investment of CHF85m to expand capsule manufacturing capacity by 30 billion capsules annually across eight sites. Source

November 2020: Roquette Launches New Vegetarian Softgel Capsule Formulations. On Roquette, a French plant-based ingredients company and pharmaceutical excipients provider, announced the launch of its pea starch technology, Lycagel, for vegetarian softgel capsule formulations. The first of its kind, according to the company, the new capsule formulation is made up of carrageenan, a setting agent found in marine macro algae, NEOSORB sorbitol, a plant-based ingredient used for nutraceutical applications, and salt, a company press release said. The new product offers significant capsule strength, seal integrity, quick drying time with no stickiness, fast disintegration, no cross-linking, and higher processing temperature suitability. Source

October 2020: Catalent Introduces New Softgel Technology. OptiGel DR softgel capsules are formed by the combination of pectin, a naturally derived polysaccharide, and gelatin, which eliminates the need for a separate capsule coating step. Catalent announced on  that it is launching OptiGel DR technology for the formulation and manufacture of delayed/enteric release softgels.OptiGel DR technology forms softgel capsules by combining pectin, a naturally derived polysaccharide, and gelatin, which eliminates the need for a separate capsule coating step, a company press release said. The capsules can also reduce gastric reflux effects. Source

April 2020: ISDIN Announces The Launch Of SunISDIN™ Softgel Capsules An oral dietary supplement designed to help skin fight photoaging from the inside out. Spains No.1 dermatological company, ISDIN®, announces the launch of SunISDIN™ Softgel Capsules to the U.S. market. This supplement features a unique VitAox ULTRA Complex, an advanced combination of antioxidants, vitamins and an essential mineral, to prepare the skin to fight photoaging, prevent oxidative stress and support general skin health. SunISDIN is designed to complement a daily skincare and sun protection routine and offers benefits for those who have concerns about fine lines and wrinkles resulting from sun exposure, or those who want to boost their overall skin health. Source